6c,d) treated with mGIPR-Ab/P1
June 2025: A petition has been filed to group together Ozempic vision loss lawsuits in New Jersey state court
Overexpression of arylsulfate sulfotransferase as fusion protein with glutathione S-transferase
The authors noted this is an off-label strategy and called for controlled trials to validate effectiveness and define who might benefit
Evidence suggests possible involvement in fibroblast activation, granulation tissue formation, and epithelialization processes
Most common side effects are: Sensitivity, soreness, or pain at the injection site, Flu-like symptoms, Headache, Dizziness, Nausea, Drowsiness, Flushing, Hives or other skin reactions, Hyperactivity or Difficulty swallowing